• International Journal of Automotive Technology
• /
• 제7권5호
• /
• pp.625-635
• /
• 2006

From a viewpoint of human factors, automated highway systems(AHS) can be defined as one of the newly developing human-machine systems that consist of humans(drivers and operators), machines(vehicles and facilities), and environments(roads and roadside environments). AHS will require a changed vehicle control process and driver-vehicle interface(DVI) comparing with conventional driving. This study introduces a fixed-based AHS simulator and provides questionnaire-based human factors evaluation results after three kinds of automated driving speed experiences in terms of road configuration, operation policies, information devices, and overall AHS use. In the simulator, the "shared space-at-grade" concept-based road configuration was virtually implemented on a portion of the Kyungbu highway in Korea, and heads-up display(HUD), AHS information display, and variable message signs(VMS) were installed for appropriate AHS DVI implementation. As the results, the subjects expressed positive opinions on the implemented road configuration, operation policies, and the overall use of AHS. The results of this study would be helpful in developing the road configuration and DVI design guideline as the basic human factors research for the future implementation of AHS.

• 한국임상수의학회지
• /
• 제34권1호
• /
• pp.1-6
• /
• 2017

Heartworm disease (HWD) in dogs is a life-threatening mosquito-borne disease resulting in right-sided congestive heart failure and inflammatory pulmonary disease. Due to complications from adulticidal therapy with melarsomine, slow kill protocol either with preventive dose of ivermectin or combined with doxycycline has been proposed for an alternative adultcidal therapy in dogs with HWD. Therefore, this study evaluated the clinical outcome of adultcidal therapy in dogs with class II stage of HWD after treating either American Heartworm Society (AHS) or slow kill protocol for 10 months. Clinical outcome after therapy was evaluated by clinical, radiographic and echocardiographic examination along with hematology before (D0) and after therapy (D300). Although clinical signs associated with HWD were all resolved after therapy in both groups, the infection was not cleared out 67% of dogs treated by slow kill protocol at the end of therapy. Furthermore, pulmonary arterial flow of acceleration time to ejection time ratio (AT/ET) and the right pulmonary artery distensibility index (RPADI) have been firstly used for detecting pulmonary hypertension in this study group. The pulmonary hypertension was more common in dogs with mild clinical signs, although tricuspid and pulmonary regurgitation were not detectable in most dogs in this study. Our study findings suggested that the slow kill protocol might not be efficacious enough to clear out HWD in dogs and more attention on the presence of pulmonary hypertension might be necessary for effective management of HWD in dogs.